Last reviewed · How we verify
NCT04398069
Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock
NA trial testing hemodynamic optimisation aiming to achieve normal cerebral perfusion in Trans Cranial Doppler Ultrasonography in Heamodynamic Optimisation in Septic Shock in 24 participants. Status unknown.
31 August 2020
Quick facts
| Lead sponsor | Mongi Slim Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 24 |
| Start date | 2 January 2020 |
| Primary completion | 31 August 2020 |
| Estimated completion | 30 October 2020 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- hemodynamic optimisation aiming to achieve normal cerebral perfusion
Conditions studied
- Trans Cranial Doppler Ultrasonography in Heamodynamic Optimisation in Septic Shock — all drugs for Trans Cranial Doppler Ultrasonography in Heamodynamic Optimisation in Septic Shock →
Sponsor
Mongi Slim Hospital
Who can join
18 and older, any sex, with Trans Cranial Doppler Ultrasonography in Heamodynamic Optimisation in Septic Shock. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic Shock, at the early phase. patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin doses: * Group 1: standard hemodynamic goals and catecholamin infusion to achieve: mean arterial pressure \> or equal to 65 mmHg and diastolic arterial pressure \> ou equal to 50 mmHg within the first 60 minutes. * Group 2: personalized hemodynamic goals and catecholamin infusion until normal transcranial doppler: IP\<1,2.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04398069
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mongi Slim Hospital trials
Trials by the same sponsor.
- NCT06511427 — Difficult Airways Scores Validation Difficult Laryngoscopy and Mask Ventilation: Prospective and Evaluative Study · not yet recruiting
- NCT06676865 — Preoperative Prediction of Difficult Laryngoscopy in Diabetic Patients: Importance of the Palm Print Test · completed
- NCT06444737 — Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia · NA · recruiting
- NCT06203353 — Evaluation of the Diaphragm Performance During Weaning From Mechanical Ventilation · unknown
- NCT06622096 — Evaluation of Lab Exams Accuracy in the Intensive Care Unit · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04398069 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mongi Slim Hospital
- Last refreshed: 21 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04398069.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing